Simrat Randhawa

DNTH

Simrat Randhawa serves as officer: EVP, Head of R&D at Dianthus Therapeutics, Inc. (DNTH). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$52.8K

Total Sells

3 trades

$12.54M

Net Position

Net Seller

$12.49M

Companies Traded

DNTH

Active Period

Sep 2023 – Jun 2026

4 total trades

Most Recent

Sell DNTH

Jun 2, 2026 · $2.40M

Simrat Randhawa's Insider Trading at Dianthus Therapeutics, Inc. (DNTH)

Buys

1 · $52.8K

Sells

3 · $12.54M

Total Shares Bought

4,000

Total Shares Sold

256,898

DNTH Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jun 2, 2026	Sell	26,530	$90.62	$2.40M	25,102
Mar 13, 2026	Sell	33,830	$81.48	$2.76M	0
Nov 13, 2025	Sell	196,538	$37.55	$7.38M	0
Sep 25, 2023	Buy	4,000	$13.20	$52.8K	4,000

Related Insiders

Ryan Savitz

officer: EVP, CFO & CBO

DNTHSell · Jul 13, 2026

Adam M Veness

officer: SVP, General Counsel and Sec.

DNTHSell · Jun 18, 2026

Paula Soteropoulos

director

DNTHSell · May 11, 2026

CARR EDWARD

officer: CHIEF ACCOUNTING OFFICER

DNTHSell · Mar 13, 2026

Marino Garcia

director, officer: CEO AND PRESIDENT

DNTHSell · Mar 13, 2026

Explore More Insider Trading Data

DNTH Insider Trading Activity

View all insider trades at Dianthus Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity